| dc.contributor.author | Ozel, Alper | |
| dc.contributor.author | Yildiz, Alaattin | |
| dc.contributor.author | Karahan, Gonca Emel | |
| dc.contributor.author | Sakaci, Tamer | |
| dc.contributor.author | Unsal, Abdulkadir | |
| dc.contributor.author | Ozkok, Abdullah | |
| dc.contributor.author | Kekik, Cigdem | |
| dc.date.accessioned | 2021-03-04T10:17:18Z | |
| dc.date.available | 2021-03-04T10:17:18Z | |
| dc.identifier.citation | Ozkok A., Kekik C., Karahan G. E. , Sakaci T., Ozel A., Unsal A., Yildiz A., "FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients", BMC NEPHROLOGY, cilt.14, 2013 | |
| dc.identifier.issn | 1471-2369 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_6c724875-3819-4635-9351-216722bd69c3 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/74965 | |
| dc.identifier.uri | https://doi.org/10.1186/1471-2369-14-241 | |
| dc.description.abstract | Background: Disordered mineral metabolism is implicated in the pathogenesis of vascular calcification in hemodialysis (HD) patients. Fibroblast growth factor 23 (FGF-23) is the main regulator of phosphate metabolism. In this prospective study, we aimed to investigate the association of serum FGF-23 with progression of coronary artery calcification in HD patients. | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | Nefroloji | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | ÜROLOJİ VE NEFROLOJİ | |
| dc.title | FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients | |
| dc.type | Makale | |
| dc.relation.journal | BMC NEPHROLOGY | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 14 | |
| dc.contributor.firstauthorID | 69856 | |
